SC

Shubham Chidanand Malawadi

Active Director Director DIN 10834133
DIN 10834133 First appointment Nov 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shubham Chidanand Malawadi

Data last updated:

Shubham Chidanand Malawadi is a Director at Shrivittal Honnakatti Hospitals Private Limited (since 2024). The company operates in Healthcare.

DIN 10834133
Primary Designation Director
Industry Healthcare
First Appointment 11 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Nov 20242024Active

Board colleagues of Shubham Chidanand Malawadi

Directorship timeline

Open interactive timeline →
Shrivittal Honnakatti Hospitals Private Limited
Premium access

Shareholding and investment profile for Shubham Chidanand Malawadi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubham Chidanand Malawadi

Shubham Chidanand Malawadi currently holds 1 directorship: Shrivittal Honnakatti Hospitals Private Limited (Director, since 11 Nov 2024).

Shubham Chidanand Malawadi was first appointed on 11 Nov 2024 as Director at Shrivittal Honnakatti Hospitals Private Limited.

The current boards of Shubham Chidanand Malawadi's companies include Avinash Kanase (Shrivittal Honnakatti Hospitals Private Limited), Kamala Honnakatti (Shrivittal Honnakatti Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available